KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Q3 2025 value amounting to 0.49.

  • Supernus Pharmaceuticals' Asset Utilization Ratio fell 82.31% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year decrease of 82.31%. This contributed to the annual value of 0.5 for FY2024, which is 2270.75% up from last year.
  • Per Supernus Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.49 for Q3 2025, which was down 82.31% from 0.49 recorded in Q2 2025.
  • Over the past 5 years, Supernus Pharmaceuticals' Asset Utilization Ratio peaked at 0.49 during Q1 2025, and registered a low of 0.36 during Q4 2021.
  • For the 5-year period, Supernus Pharmaceuticals' Asset Utilization Ratio averaged around 0.43, with its median value being 0.41 (2023).
  • Per our database at Business Quant, Supernus Pharmaceuticals' Asset Utilization Ratio crashed by 220.99% in 2022 and then surged by 2175.35% in 2023.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Asset Utilization Ratio stood at 0.36 in 2021, then rose by 9.95% to 0.39 in 2022, then rose by 20.64% to 0.47 in 2023, then increased by 2.99% to 0.49 in 2024, then decreased by 0.38% to 0.49 in 2025.
  • Its Asset Utilization Ratio was 0.49 in Q3 2025, compared to 0.49 in Q2 2025 and 0.49 in Q1 2025.